atypical antipsychotic agent

atypical antipsychotic agent

a functional category of newer antipsychotic drugs thought to exert their action predominantly through serotonergic blockade; now frequently called second-generation antipsychotics.

a·typ·i·cal an·ti·psy·chot·ic a·gent

(ā-tip'i-kăl an'tē-sī-kot'ik ā'jĕnt)
A functional category of newer antipsychotic drugs (e.g., olanzapine, clozapine) thought to exert their action predominantly through serotonergic blockade.
References in periodicals archive ?
LATUDA is an atypical antipsychotic agent created by Sumitomo Dainippon Pharma.
If this combination doesn't provide satisfactory improvement after adequate dosing for sufficient duration, only then is it time to turn to an atypical antipsychotic agent as a higher-risk/higher-reward third-line therapy, added Dr.
The multicenter, randomized, double-blind phase 3 study will evaluate the weight gain profile of ALKS 3831 compared to olanzapine, an established atypical antipsychotic agent with proven efficacy but also metabolic liabilities, in patients with stable schizophrenia over a six-month treatment period.
According to the company, Fanapt is an atypical antipsychotic agent indicated for the treatment of schizophrenia in adults.
Clozapine, the first atypical antipsychotic agent, is the medication of choice when TRS is confirmed, and many studies have demonstrated its superiority over other antipsychotic compounds in such cases (6-8).
announced that they have entered into a license agreement for the commercialization of lurasidone hydrochloride ("lurasidone"), an atypical antipsychotic agent discovered by DSP, in Brazil and Venezuela.
This atypical antipsychotic agent, which was used in the study at a mean daily dose of just 7.4 mg, is a novel therapy worth considering in selected geriatric patients with bipolar disorder, Dr.
Clozapine was the first introduced atypical antipsychotic agent and it leads to a short-lived and slight increase of plasma prolactin which may remain undetected in routine laboratory controls [1, 3, 14].
Risperidone (Risperdal), an atypical antipsychotic agent manufactured by Janssen Pharmaceutica, was approved in 1993 for treatment of adults with schizophrenia.
INDIANAPOLIS--Zyprexa has been approved as a longterm schizophrenia therapy and for maintenance of treatment response, making it the first atypical antipsychotic agent to receive the indication.
Clozapine (Clozaril), the only atypical antipsychotic agent currently marketed in the United States, has been found to be beneficial to some patients who have not responded to treatment with traditional antipsychotic medications or could not tolerate traditional antipsychotic medication because of severe side effects.
Lurasidone is an atypical antipsychotic agent that is believed to have an affinity for dopamine D2, serotonin 5-HT2A and serotonin 5-HT7 receptors where it has antagonist effects.